• In late February 2026, Alphatec Holdings, Inc. reported that its fourth-quarter 2025 net loss narrowed to US$21.73 million and full-year net loss improved to US$143.36 million, while reaffirming its 2026 revenue outlook of about US$890 million.
• Management also highlighted strong surgeon adoption, double-digit surgical volume and revenue growth in 2025, and a goal to generate US$20 million in free cash flow in 2026, underscoring its focus on scaling an integrated spine surgery platform.
• With Alphatec reaffirming its ambitious 2026 revenue outlook, we’ll examine how this guidance update reshapes the company’s investment narrative.

We've uncovered the 15 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Alphatec Holdings Investment Narrative Recap

To own Alphatec, you need to believe its integrated spine platform can translate surgeon adoption and procedure growth into sustained revenue gains while steadily narrowing losses. The latest results, with a smaller 2025 net loss and reaffirmed 2026 revenue outlook of about US$890 million, support the near term growth catalyst of volume expansion but do not materially change the key risk that ongoing losses and heavy investment could pressure the balance sheet if growth slows.

The reaffirmed 2026 revenue guidance is the most relevant update here, because it anchors expectations around Alphatec’s ability to convert 2025’s strong surgeon adoption and double digit surgical volume growth into meaningful top line expansion. That same outlook also frames management’s target of generating about US$20 million in free cash flow in 2026, which sits at the heart of the current debate about when the business can begin to self fund its innovation engine.

Yet the biggest thing investors should be aware of is the risk that continued operating losses and heavy investment could collide with...

Alphatec Holdings' narrative projects $1.1 billion revenue and $93.9 million earnings by 2028. This requires 17.4% yearly revenue growth and a $259.9 million earnings increase from -$166.0 million today.

Uncover how Alphatec Holdings' forecasts yield a $24.62 fair value, a 81% upside to its current price.

Exploring Other Perspectives

While consensus focuses on steady growth and narrowing losses, the most optimistic analysts once expected revenue of about US$1.2 billion and US$112 million in earnings by 2028, highlighting how differently you might weigh today’s reaffirmed US$890 million guidance against the risk that Alphatec’s premium spine focus faces mounting pricing pressure and technology shifts.

Explore 3 other fair value estimates on Alphatec Holdings - why the stock might be worth as much as 89% more than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Alphatec Holdings research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Alphatec Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Alphatec Holdings' overall financial health at a glance.

Contemplating Other Strategies?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Capitalize on the AI infrastructure supercycle with our selection of the 34 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Find 46 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.